ARCHIVES

Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says

This article is from The Cancer Letter archive.

Vol. 23 No. 22 | June 6, 1997

Download PDF Visit The Full Archive

Related Articles

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009